HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 06-MAR-14 4PRR TITLE HUMAN ALDOSE REDUCTASE COMPLEXED WITH SCHL7815 ((3-[3-(5-NITROFURAN-2- TITLE 2 YL)PHENYL]PROPANOIC ACID)AT 1.01 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HUMAN ALDOSE REDUCTASE; COMPND 5 SYNONYM: AR, ALDEHYDE REDUCTASE, ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 6 B1; COMPND 7 EC: 1.1.1.21; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TIM BARREL, OXIDOREDUCTASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.RECHLIN,A.HEINE,G.KLEBE REVDAT 2 20-SEP-23 4PRR 1 REMARK REVDAT 1 08-APR-15 4PRR 0 JRNL AUTH C.RECHLIN,A.HEINE,R.ORTMANN,M.SCHLITZER,G.KLEBE JRNL TITL KEYS TO OPEN THE SPECIFICITY POCKET: BIPHENYLIC INHIBITORS JRNL TITL 2 OF THE HUMAN ALDOSE REDUCTASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 148093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.144 REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.155 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7408 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 18.7790 - 3.1310 0.92 4775 262 0.1576 0.1567 REMARK 3 2 3.1310 - 2.4870 0.98 5006 272 0.1607 0.1796 REMARK 3 3 2.4870 - 2.1732 0.97 4994 254 0.1530 0.1606 REMARK 3 4 2.1732 - 1.9747 0.96 4866 255 0.1451 0.1444 REMARK 3 5 1.9747 - 1.8333 0.96 4909 261 0.1509 0.1602 REMARK 3 6 1.8333 - 1.7253 0.95 4847 253 0.1495 0.1665 REMARK 3 7 1.7253 - 1.6390 0.95 4804 246 0.1383 0.1468 REMARK 3 8 1.6390 - 1.5676 0.94 4745 264 0.1310 0.1363 REMARK 3 9 1.5676 - 1.5073 0.94 4799 253 0.1270 0.1455 REMARK 3 10 1.5073 - 1.4553 0.94 4759 252 0.1239 0.1271 REMARK 3 11 1.4553 - 1.4098 0.94 4792 245 0.1200 0.1317 REMARK 3 12 1.4098 - 1.3696 0.94 4751 260 0.1150 0.1212 REMARK 3 13 1.3696 - 1.3335 0.94 4753 264 0.1155 0.1353 REMARK 3 14 1.3335 - 1.3010 0.93 4707 278 0.1174 0.1454 REMARK 3 15 1.3010 - 1.2714 0.93 4692 256 0.1172 0.1391 REMARK 3 16 1.2714 - 1.2444 0.92 4684 233 0.1178 0.1346 REMARK 3 17 1.2444 - 1.2195 0.92 4682 256 0.1183 0.1362 REMARK 3 18 1.2195 - 1.1965 0.93 4716 227 0.1215 0.1511 REMARK 3 19 1.1965 - 1.1751 0.92 4667 242 0.1202 0.1310 REMARK 3 20 1.1751 - 1.1552 0.91 4595 261 0.1206 0.1322 REMARK 3 21 1.1552 - 1.1366 0.92 4607 251 0.1276 0.1355 REMARK 3 22 1.1366 - 1.1191 0.92 4665 238 0.1315 0.1462 REMARK 3 23 1.1191 - 1.1026 0.91 4624 243 0.1428 0.1579 REMARK 3 24 1.1026 - 1.0871 0.91 4627 230 0.1472 0.1699 REMARK 3 25 1.0871 - 1.0724 0.90 4508 238 0.1584 0.1673 REMARK 3 26 1.0724 - 1.0585 0.89 4574 232 0.1605 0.1858 REMARK 3 27 1.0585 - 1.0452 0.89 4490 229 0.1743 0.2048 REMARK 3 28 1.0452 - 1.0326 0.88 4473 240 0.1928 0.2355 REMARK 3 29 1.0326 - 1.0206 0.87 4422 234 0.2038 0.2368 REMARK 3 30 1.0206 - 1.0092 0.82 4152 179 0.2256 0.2659 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.070 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 13.670 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 7.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2719 REMARK 3 ANGLE : 1.253 3731 REMARK 3 CHIRALITY : 0.078 416 REMARK 3 PLANARITY : 0.007 478 REMARK 3 DIHEDRAL : 13.952 1018 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PRR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000085138. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : SILICON, ACTIVE SURACE 50 NM RH REMARK 200 -COATED REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 148147 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.010 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 16.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.42100 REMARK 200 FOR SHELL : 2.040 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2DUX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DI-AMMONIUMHYDROGEN CITRATE PH 5.0, REMARK 280 PEG6000= 5 % (M/V), DTT= 5.15 G/L, ADP= 0,66 G/L, PROTEIN 15 MG/ REMARK 280 ML. SOAKING CONDITIONS: TRIS BUFFER, TRIS 100 MM 25 %(M/V) REMARK 280 PEG6000 PH 8.0 SATURATED WITH THE INHIBITOR, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.43150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 63 NE CZ NH1 NH2 REMARK 470 GLU A 70 CD OE1 OE2 REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 LYS A 119 CD CE NZ REMARK 470 GLU A 126 CD OE1 OE2 REMARK 470 HIS A 163 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 178 NZ REMARK 470 LYS A 194 CG CD CE NZ REMARK 470 LYS A 221 CD CE NZ REMARK 470 GLU A 229 OE1 OE2 REMARK 470 LYS A 234 CE NZ REMARK 470 GLU A 267 CD OE1 OE2 REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 ARG A 293 NE CZ NH1 NH2 REMARK 470 GLU A 313 OE1 OE2 REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 AUTHORS HAVE INDICATED THAT THE SEQUENCING RESULT OF THE PLASMID REMARK 600 SHOWED A ILE IN POSITION 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2W9 A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IKG RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE STRUCTURE WITH INHIBITOR FROM THE SAME GROUP REMARK 900 RELATED ID: 2IKH RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE STRUCTURE WITH INHIBITOR FROM THE SAME GROUP REMARK 900 RELATED ID: 3DN5 RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE STRUCTURE WITH INHIBITOR FROM THE SAME GROUP REMARK 900 RELATED ID: 4NKC RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE STRUCTURE WITH INHIBITOR FROM THE SAME GROUP REMARK 900 RELATED ID: 4PR4 RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE STRUCTURE WITH INHIBITOR FROM THE SAME GROUP REMARK 900 RELATED ID: 4PRT RELATED DB: PDB DBREF 4PRR A 1 315 UNP P15121 ALDR_HUMAN 2 316 SEQADV 4PRR ILE A 4 UNP P15121 LEU 5 SEE REMARK 999 SEQRES 1 A 315 ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET PRO SEQRES 2 A 315 ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY GLN SEQRES 3 A 315 VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY TYR SEQRES 4 A 315 ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU ASN SEQRES 5 A 315 GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU GLN SEQRES 6 A 315 VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS LEU SEQRES 7 A 315 TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY ALA SEQRES 8 A 315 CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR LEU SEQRES 9 A 315 ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS PRO SEQRES 10 A 315 GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN VAL SEQRES 11 A 315 VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA ALA SEQRES 12 A 315 MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA ILE SEQRES 13 A 315 GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET ILE SEQRES 14 A 315 LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL ASN SEQRES 15 A 315 GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS LEU SEQRES 16 A 315 ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR ALA SEQRES 17 A 315 TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA LYS SEQRES 18 A 315 PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE LYS SEQRES 19 A 315 ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN VAL SEQRES 20 A 315 LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL ILE SEQRES 21 A 315 PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN PHE SEQRES 22 A 315 LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET THR SEQRES 23 A 315 THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS ALA SEQRES 24 A 315 LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE HIS SEQRES 25 A 315 GLU GLU PHE HET NAP A 401 48 HET 2W9 A 402 19 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 2W9 3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 2W9 C13 H11 N O5 FORMUL 4 HOH *334(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 GLU A 84 GLY A 86 5 3 HELIX 7 7 LEU A 87 LYS A 100 1 14 HELIX 8 8 ASN A 136 GLU A 150 1 15 HELIX 9 9 ASN A 162 ASN A 171 1 10 HELIX 10 10 GLN A 192 LYS A 202 1 11 HELIX 11 11 SER A 226 GLU A 229 5 4 HELIX 12 12 ASP A 230 HIS A 240 1 11 HELIX 13 13 THR A 243 GLN A 254 1 12 HELIX 14 14 THR A 265 LYS A 274 1 10 HELIX 15 15 SER A 281 SER A 290 1 10 HELIX 16 16 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 B 8 GLY A 16 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 35 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 35 ASP A 43 TYR A 48 HIS A 110 TRP A 111 SITE 3 AC1 35 SER A 159 ASN A 160 GLN A 183 TYR A 209 SITE 4 AC1 35 SER A 210 PRO A 211 LEU A 212 GLY A 213 SITE 5 AC1 35 SER A 214 PRO A 215 ASP A 216 ALA A 245 SITE 6 AC1 35 ILE A 260 PRO A 261 LYS A 262 SER A 263 SITE 7 AC1 35 VAL A 264 THR A 265 ARG A 268 GLU A 271 SITE 8 AC1 35 ASN A 272 2W9 A 402 HOH A 669 HOH A 690 SITE 9 AC1 35 HOH A 691 HOH A 745 HOH A 795 SITE 1 AC2 9 TRP A 20 TYR A 48 HIS A 110 TRP A 111 SITE 2 AC2 9 TRP A 219 LEU A 300 CYS A 303 TYR A 309 SITE 3 AC2 9 NAP A 401 CRYST1 49.305 66.863 47.214 90.00 92.54 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020282 0.000000 0.000899 0.00000 SCALE2 0.000000 0.014956 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021201 0.00000